These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

358 related items for PubMed ID: 7472821

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Biologic activities of antibodies to the neutral-polysaccharide component of the Pseudomonas aeruginosa lipopolysaccharide are blocked by O side chains and mucoid exopolysaccharide (alginate).
    Hatano K, Goldberg JB, Pier GB.
    Infect Immun; 1995 Jan; 63(1):21-6. PubMed ID: 7528730
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Effector mechanisms of protection against Pseudomonas aeruginosa keratitis in immunized rats.
    Thakur A, Kyd J, Xue M, Willcox MD, Cripps A.
    Infect Immun; 2001 May; 69(5):3295-304. PubMed ID: 11292752
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Mucosal and systemic antibody responses to potential Pseudomonas aeruginosa vaccine protein antigens in young children with cystic fibrosis following colonization and infection.
    Moore R, Kyd JM, Carzino R, Armstrong D, Grimwood K, Otczyk DC, Cripps AW.
    Hum Vaccin Immunother; 2013 Mar; 9(3):506-14. PubMed ID: 23249482
    [Abstract] [Full Text] [Related]

  • 30. Vaccination promotes TH1-like inflammation and survival in chronic Pseudomonas aeruginosa pneumonia in rats.
    Johansen HK, Hougen HP, Cryz SJ, Rygaard J, Høiby N.
    Am J Respir Crit Care Med; 1995 Oct; 152(4 Pt 1):1337-46. PubMed ID: 7551392
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Intranasal Peptide-Based FpvA-KLH Conjugate Vaccine Protects Mice From Pseudomonas aeruginosa Acute Murine Pneumonia.
    Sen-Kilic E, Blackwood CB, Boehm DT, Witt WT, Malkowski AC, Bevere JR, Wong TY, Hall JM, Bradford SD, Varney ME, Damron FH, Barbier M.
    Front Immunol; 2019 Oct; 10():2497. PubMed ID: 31708925
    [Abstract] [Full Text] [Related]

  • 35. IL-17 is a critical component of vaccine-induced protection against lung infection by lipopolysaccharide-heterologous strains of Pseudomonas aeruginosa.
    Priebe GP, Walsh RL, Cederroth TA, Kamei A, Coutinho-Sledge YS, Goldberg JB, Pier GB.
    J Immunol; 2008 Oct 01; 181(7):4965-75. PubMed ID: 18802100
    [Abstract] [Full Text] [Related]

  • 36. Lipopolysaccharide (LPS), LPS-immune complexes and cytokines as inducers of pulmonary inflammation in patients with cystic fibrosis and chronic Pseudomonas aeruginosa lung infection.
    Kronborg G.
    APMIS Suppl; 1995 Oct 01; 50():1-30. PubMed ID: 7756034
    [Abstract] [Full Text] [Related]

  • 37. Enhancement of lipopolysaccharide-induced tumor necrosis factor secretion by hyperimmune serum from chronic infected patients.
    Kronborg G, Fomsgaard A, Høiby N.
    Med Microbiol Immunol; 1993 Dec 01; 182(6):305-16. PubMed ID: 8121331
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Assessment of IgG antibodies to Pseudomonas aeruginosa in patients with cystic fibrosis by an enzyme-linked immunosorbent assay (ELISA).
    Mauch RM, Rossi CL, Ribeiro JD, Ribeiro AF, Nolasco da Silva MT, Levy CE.
    Diagn Pathol; 2014 Aug 22; 9():158. PubMed ID: 25146522
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.